查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1946354

肺功能監測設備市場－全球產業規模、佔有率、趨勢、機會及預測（依產品類型、最終用戶、地區及競爭格局分類，2021-2031年）

Lung Monitoring Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球肺部監測設備市場預計將從 2025 年的 41.6 億美元成長到 2031 年的 61.1 億美元，複合年成長率達到 6.62%。

肺功能監測設備是專門用於診斷和治療的儀器，旨在評估關鍵的呼吸參數，例如氣體交換、肺容量和氣流阻塞情況，從而有效管理肺部疾病。市場成長的主要促進因素是慢性呼吸系統疾病盛行率的上升以及老年人口的成長，老年人更容易患肺部疾病。例如，國際藥學聯合會 (FIP) 報告稱，到 2024 年，全球將有 3.91 億人患有慢性阻塞性肺病(COPD)，這使得人們迫切需要準確的評估工具來預防長期併發症，並推動醫療機構對這些設備的廣泛應用。

市場概覽
預測期 2027-2031
市場規模：2025年 41.6億美元
市場規模：2031年 61.1億美元
複合年成長率：2026-2031年 6.62%
成長最快的細分市場 肺計量計
最大的市場 北美洲

然而，由於先進監測系統的高昂實施成本以及不完善的報銷體系（尤其是在新興經濟體），該市場面臨許多障礙。這些經濟障礙阻礙了低收入地區的醫療服務提供者獲得最新的呼吸照護技術，從而有效地限制了市場滲透率。儘管臨床上對全面呼吸健康管理的需求日益成長，但這些經濟限制阻礙了市場擴張，並使最需要這些工具的地區無法獲得必要的診斷工具。

市場促進因素

智慧穿戴式監測設備的科技進步正在革新全球肺部監測設備市場，顯著提升診斷準確性和患者便利性。人工智慧和非接觸式感測器的應用，無需依賴笨重的硬體即可對呼吸功能進行連續評估，這與行業向無創、便捷解決方案轉型的趨勢相契合。例如，2025年6月，Mindset Medical宣布其一款純軟體應用程式已獲得FDA核准，該程式能夠利用標準智慧型手機相機測量呼吸頻率。這項進展表明，數位健康工具正在降低進入門檻，並促進呼吸追蹤技術在不同患者群體中的普及應用。

同時，隨著醫療系統尋求減少住院治療，遠端患者監護和居家醫療的興起創造了巨大的市場機會。這一趨勢的驅動力在於，人們需要在傳統臨床環境之外進行慢性病管理，而日益惡化的環境因素尤其加劇了這種需求。美國肺臟協會指出，到2025年，美國將有約1.56億人居住在空氣污染水平不健康的地區，這將持續推高對家庭管理解決方案的需求。因此，主要市場參與者正從這些分散式模式中實現強勁成長。瑞思邁（ResMed）公佈，截至2025年7月的會計年度收入達13億美元，年增10%，凸顯了遠距呼吸照護技術的商業性可行性及其日益普及。

市場挑戰

全球肺部監測設備市場的擴張受到高昂的實施成本和先進監測系統報銷體係不足的顯著限制。醫療機構，尤其是在新興經濟體，往往面臨嚴重的資金限制，難以投資購買現代化的診斷設備。當保險公司和公共醫療計畫未能充分涵蓋這些技術時，這種障礙會進一步加劇，使得許多醫療機構難以負擔先進的呼吸系統治療。因此，醫院被迫推遲必要的設備升級，這直接阻礙了精準監測工具的普及，並限制了呼吸系統疾病負擔尤其沉重的地區的市場滲透率。

經濟上的不便不僅降低了潛在的市場收入，也導致患者照護效率低下，造成巨大的經濟損失。無法採用這些設備會導致診斷延誤和疾病管理不善。據歐洲呼吸學會稱，到2025年，慢性呼吸系統疾病的漏診和誤診將導致歐洲地區每年損失約210億美元。這一數字凸顯了資金短缺和財務限制如何阻礙監測解決方案的廣泛應用，使市場無法充分發揮其潛力，同時加重醫療保健系統的長期經濟負擔。

市場趨勢

多功能心肺監測設備的研發正在改變市場格局，它將多種診斷功能整合到緊湊的臨床級工具中，用於進行全面的健康評估。鑑於心肺功能在慢性病管理中的重要性，製造商正在加速研發能夠同時追蹤心血管和肺功能指標的設備。這種整合化設計無需使用多個獨立設備，提高了患者的便利性，並增強了遠端臨床評估的數據品質。例如，Withings公司於2025年11月獲得了FDA對其BeamO的批准。 BeamO是一款四合一多功能設備，將數位聽診器、心電圖儀和血氧儀整合於一個攜帶式單元中，零售價為249.95美元（約32,000日圓）。

同時，隨著業界重心從被動給藥轉向提高用藥依從性和數據驅動的治療管理，智慧互聯吸入器和霧化器的應用正加速發展。這些新一代系統與數位健康生態系統連接，彌合了患者與醫療服務提供者之間的鴻溝，確保呼吸系統治療得到正確實施並進行即時監測。這種互聯性支持主動介入策略，有助於預防疾病進展並減輕急診醫療機構的負擔。Omron Healthcare於2025年10月宣布，其霧化器累計銷量已突破5000萬台，這正反映了這一趨勢，也展現了呼吸管理解決方案在互聯醫療網路中的全球規模和不斷擴大的覆蓋範圍。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球肺功能監測設備市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品類型（肺計量計、脈動式血氧監測儀系統、二氧化碳測量儀、其他）
    • 按最終使用者（醫院/診所、門診護理中心、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美肺功能監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲肺功能監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區肺功能監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲肺功能監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章 南美洲肺功能監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球肺功能監測設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Baxter International Inc.
  • Becton, Dickinson and Company
  • ICU Medical Inc.
  • Koninklijke Philips NV
  • Masimo Corporation
  • Medtronic plc
  • Nihon Kohden Corporation
  • ResMed Inc.
  • Teleflex Incorporated.
  • Vyaire Medical, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 19509

The Global Lung Monitoring Devices Market is projected to expand from USD 4.16 Billion in 2025 to USD 6.11 Billion by 2031, achieving a compound annual growth rate of 6.62%. Lung monitoring devices are specialized diagnostic and therapeutic tools designed to evaluate critical respiratory parameters, such as gas exchange, lung capacity, and airflow obstruction, ensuring effective management of pulmonary conditions. The market's growth is primarily driven by the increasing prevalence of chronic respiratory disorders and a growing geriatric population that is highly susceptible to lung ailments. For instance, the International Pharmaceutical Federation reported in 2024 that 391 million individuals globally were living with chronic obstructive pulmonary disease, creating an urgent need for accurate assessment tools to prevent long-term complications and driving their adoption across healthcare facilities.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 4.16 Billion
Market Size 2031USD 6.11 Billion
CAGR 2026-20316.62%
Fastest Growing SegmentSpirometers
Largest MarketNorth America

However, the market faces a significant obstacle in the form of high acquisition costs for advanced monitoring systems, particularly when combined with insufficient reimbursement frameworks in emerging economies. These financial barriers restrict access to modern respiratory care technologies for healthcare providers in low-income regions, effectively limiting market penetration. Despite the growing clinical necessity for comprehensive respiratory health management, these economic constraints prevent the broader expansion of the market and hinder the availability of essential diagnostic tools in areas where they are often needed most.

Market Driver

Technological advancements in smart and wearable monitoring devices are revolutionizing the Global Lung Monitoring Devices Market by significantly improving diagnostic precision and patient convenience. The incorporation of artificial intelligence and contactless sensors enables the continuous evaluation of respiratory functions without relying on cumbersome hardware, aligning with the industry's shift toward non-invasive, accessible solutions. For example, Mindset Medical announced in June 2025 that it received FDA clearance for a software-only application capable of measuring respiratory rates using standard smartphone cameras. This development illustrates how digital health tools are lowering barriers to entry and fostering the widespread adoption of respiratory tracking technologies across a diverse range of patient demographics.

Simultaneously, the transition toward remote patient monitoring and home healthcare is creating substantial market opportunities as healthcare systems aim to decrease hospital admissions. This trend is fueled by the necessity to manage chronic conditions outside traditional clinical settings, a need intensified by worsening environmental factors. The American Lung Association noted in 2025 that approximately 156 million people in the U.S. lived in areas with unhealthy air pollution levels, sustaining the demand for home-based management solutions. Consequently, major market players are experiencing robust growth from these decentralized models; ResMed reported a 10% revenue increase to $1.3 billion in its July 2025 quarterly results, highlighting the commercial viability and rising uptake of remote respiratory care technologies.

Market Challenge

The expansion of the Global Lung Monitoring Devices Market is heavily restricted by the high acquisition costs of advanced monitoring systems and inadequate reimbursement structures. Healthcare facilities, particularly those in emerging economies, often face significant capital constraints that prevent investment in modern diagnostic equipment. This barrier is exacerbated when insurers and public health programs provide insufficient coverage for these technologies, making advanced respiratory care financially unfeasible for many providers. As a result, hospitals are frequently forced to delay necessary equipment upgrades, which directly stifles the adoption of precise monitoring tools and limits market penetration in regions where the burden of respiratory disease is often highest.

This lack of financial accessibility not only reduces potential market revenue but also creates inefficiencies in patient care that lead to substantial economic losses. The inability to deploy these devices contributes to missed diagnoses and poor disease management. According to the European Respiratory Society, in 2025, the underdiagnosis and misdiagnosis of chronic respiratory diseases cost the European region an estimated $21 billion annually. This figure underscores how funding gaps and financial constraints impede the widespread integration of monitoring solutions, preventing the market from reaching its full potential while increasing the long-term economic strain on healthcare systems.

Market Trends

The development of multi-parameter cardio-respiratory devices is transforming the market by consolidating various diagnostic functions into compact, clinical-grade tools for holistic health assessment. Manufacturers are increasingly designing devices that simultaneously track cardiovascular and pulmonary metrics, acknowledging the critical relationship between heart and lung function in the management of chronic diseases. This convergence simplifies the patient experience by eliminating the need for multiple disparate gadgets and enhances the quality of data available for remote clinical evaluation. For instance, Withings received FDA clearance in November 2025 for its BeamO device, a 4-in-1 multiscope retailing for $249.95 that combines a digital stethoscope, electrocardiogram, and oximeter into a single handheld unit.

In parallel, the adoption of smart connected inhalers and nebulizers is gaining momentum as the industry shifts priority toward medication adherence and data-driven therapeutic management rather than passive drug delivery. These next-generation systems integrate with digital health ecosystems to bridge the gap between patients and providers, ensuring respiratory treatments are administered correctly and monitored in real-time. This connectivity supports proactive intervention strategies that can prevent disease progression and reduce the burden on acute care facilities. Highlighting this trend, Omron Healthcare announced in October 2025 that cumulative sales of its nebulizers had surpassed 50 million units, demonstrating the massive global scale and growing reach of these respiratory management solutions within connected care networks.

Key Market Players

  • Baxter International Inc.
  • Becton, Dickinson and Company
  • ICU Medical Inc.
  • Koninklijke Philips N.V.
  • Masimo Corporation
  • Medtronic plc
  • Nihon Kohden Corporation
  • ResMed Inc.
  • Teleflex Incorporated.
  • Vyaire Medical, Inc.

Report Scope

In this report, the Global Lung Monitoring Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Lung Monitoring Devices Market, By Product Type

  • Spirometers
  • Pulse Oximeters
  • Capnographs
  • Others

Lung Monitoring Devices Market, By End User

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Lung Monitoring Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Lung Monitoring Devices Market.

Available Customizations:

Global Lung Monitoring Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Lung Monitoring Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Spirometers, Pulse Oximeters, Capnographs, Others)
    • 5.2.2. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Lung Monitoring Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Lung Monitoring Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Lung Monitoring Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Lung Monitoring Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By End User

7. Europe Lung Monitoring Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Lung Monitoring Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By End User
    • 7.3.2. France Lung Monitoring Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Lung Monitoring Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Lung Monitoring Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Lung Monitoring Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By End User

8. Asia Pacific Lung Monitoring Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Lung Monitoring Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By End User
    • 8.3.2. India Lung Monitoring Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Lung Monitoring Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Lung Monitoring Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Lung Monitoring Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By End User

9. Middle East & Africa Lung Monitoring Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Lung Monitoring Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By End User
    • 9.3.2. UAE Lung Monitoring Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By End User
    • 9.3.3. South Africa Lung Monitoring Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By End User

10. South America Lung Monitoring Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Lung Monitoring Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Colombia Lung Monitoring Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By End User
    • 10.3.3. Argentina Lung Monitoring Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Lung Monitoring Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Baxter International Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Becton, Dickinson and Company
  • 15.3. ICU Medical Inc.
  • 15.4. Koninklijke Philips N.V.
  • 15.5. Masimo Corporation
  • 15.6. Medtronic plc
  • 15.7. Nihon Kohden Corporation
  • 15.8. ResMed Inc.
  • 15.9. Teleflex Incorporated.
  • 15.10. Vyaire Medical, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer